Julia K. Tietze

3.2k total citations
45 papers, 1.1k citations indexed

About

Julia K. Tietze is a scholar working on Oncology, Dermatology and Immunology. According to data from OpenAlex, Julia K. Tietze has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Dermatology and 13 papers in Immunology. Recurrent topics in Julia K. Tietze's work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (11 papers). Julia K. Tietze is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (11 papers). Julia K. Tietze collaborates with scholars based in Germany, United States and Taiwan. Julia K. Tietze's co-authors include Markus V. Heppt, Thomas Ruzicka, Carola Berking, Thomas Eigentler, William J. Murphy, Lisa Zimmer, Markus Reinholz, Ralf Gutzmer, Oliver Bähr and Xin Ding and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Julia K. Tietze

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia K. Tietze Germany 19 561 438 162 159 125 45 1.1k
Sadanori Furudate Japan 17 553 1.0× 411 0.9× 184 1.1× 223 1.4× 117 0.9× 72 1.0k
Azusa Miyashita Japan 16 625 1.1× 393 0.9× 284 1.8× 99 0.6× 131 1.0× 42 1.0k
Joanna Mangana Switzerland 20 710 1.3× 292 0.7× 441 2.7× 110 0.7× 150 1.2× 82 1.2k
Courtney W. Hudgens United States 16 544 1.0× 269 0.6× 215 1.3× 94 0.6× 116 0.9× 30 877
Laura K. Fogli United States 8 385 0.7× 157 0.4× 317 2.0× 79 0.5× 64 0.5× 17 754
Mitali Manzur Australia 10 254 0.5× 386 0.9× 376 2.3× 60 0.4× 44 0.4× 12 885
Leila Jeskanen Finland 21 308 0.5× 161 0.4× 248 1.5× 213 1.3× 50 0.4× 39 1.1k
Amy J. Petty United States 11 344 0.6× 497 1.1× 271 1.7× 62 0.4× 80 0.6× 20 854
Jochen T. Schaefer United States 11 480 0.9× 430 1.0× 151 0.9× 96 0.6× 81 0.6× 17 802
Özge Uluçkan United States 17 284 0.5× 252 0.6× 329 2.0× 87 0.5× 72 0.6× 25 907

Countries citing papers authored by Julia K. Tietze

Since Specialization
Citations

This map shows the geographic impact of Julia K. Tietze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia K. Tietze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia K. Tietze more than expected).

Fields of papers citing papers by Julia K. Tietze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia K. Tietze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia K. Tietze. The network helps show where Julia K. Tietze may publish in the future.

Co-authorship network of co-authors of Julia K. Tietze

This figure shows the co-authorship network connecting the top 25 collaborators of Julia K. Tietze. A scholar is included among the top collaborators of Julia K. Tietze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia K. Tietze. Julia K. Tietze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forschner, Andrea, Ulrike Leiter, Friedegund Meier, et al.. (2024). Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors. European Journal of Cancer. 203. 114028–114028. 24 indexed citations
2.
Weide, Benjamin, et al.. (2023). Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab. Oncology. 102(1). 76–84. 1 indexed citations
3.
Spitzer, Carsten, et al.. (2022). Prevalence of pathological skin-picking in dermatological patients. Journal of Psychiatric Research. 147. 232–236. 5 indexed citations
4.
Schulz, Alexander, Julia K. Tietze, Bertold Renner, et al.. (2022). Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma. Cancers. 14(19). 4930–4930. 10 indexed citations
5.
Tietze, Julia K.. (2022). Tumorinfiltrierende T-Zellen und natürliche Killerzellen im Melanom. Die Dermatologie. 73(12). 929–936. 2 indexed citations
6.
Hoch, Matti, Frank Weber, Julia K. Tietze, et al.. (2021). The Response and Tolerability of a Novel Cold Atmospheric Plasma Wound Dressing for the Healing of Split Skin Graft Donor Sites: A Controlled Pilot Study. Skin Pharmacology and Physiology. 34(6). 328–336. 24 indexed citations
7.
Arakawa, Akiko, Sigrid Vollmer, Julia K. Tietze, et al.. (2019). Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma. Frontiers in Immunology. 10. 1336–1336. 51 indexed citations
8.
Tietze, Julia K., Andrea Forschner, Carmen Loquai, et al.. (2018). The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study. Oncotarget. 9(76). 34336–34346. 24 indexed citations
9.
Letulé, Valerie, Markus Reinholz, Julia K. Tietze, et al.. (2017). Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center. Facial Plastic Surgery. 34(1). 88–94. 31 indexed citations
10.
Tietze, Julia K., et al.. (2017). Stabile Erkrankung oder vollständiges Ansprechen?. Der Hautarzt. 68(8). 632–638. 1 indexed citations
11.
Heppt, Markus V., Thomas Eigentler, Katharina C. Kähler, et al.. (2016). Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. Cancer Immunology Immunotherapy. 65(8). 951–959. 60 indexed citations
12.
Reinholz, Markus, Markus V. Heppt, Julia K. Tietze, et al.. (2015). Topical 0.5% brimonidine gel to camouflage redness of immature scars. Journal of Dermatological Case Reports. 9(3). 2 indexed citations
13.
Tietze, Julia K., Markus V. Heppt, U. Wolf, et al.. (2015). Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients. Journal of the European Academy of Dermatology and Venereology. 29(9). 1816–1821. 19 indexed citations
14.
Tietze, Julia K. & Carola Berking. (2015). Endlich neue Therapieoptionen beim malignen Melanom. TumorDiagnostik & Therapie. 36(3). 150–156.
15.
Reiser, Maximilian F., Felix Beuschlein, Andrea Oßwald, et al.. (2014). Linear and Volumetric Evaluation of the Adrenal Gland—MDCT-Based Measurements of the Adrenals. Academic Radiology. 21(11). 1465–1474. 36 indexed citations
16.
Monjazeb, Arta M., Julia K. Tietze, Steven K. Grossenbacher, et al.. (2014). Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help. PLoS ONE. 9(8). e102709–e102709. 24 indexed citations
17.
Tietze, Julia K., Gail D. Sckisel, Hui-Hua Hsiao, & William J. Murphy. (2011). Antigen-specific versus Antigen-nonspecific Immunotherapeutic Approaches for Human Melanoma: The Need for Integration for Optimal Efficacy?. International Reviews of Immunology. 30(5-6). 238–293. 3 indexed citations
18.
Katzer, K., Julia K. Tietze, Elisabeth Klein, et al.. (2010). Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab – A report of 29 patients. European Journal of Dermatology. 20(1). 82–84. 19 indexed citations
19.
Klövekorn, Winfried, Hans Christian Körting, Percy Lehmann, et al.. (2009). Rosazea. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 7(11). 996–1003. 3 indexed citations
20.
Beyersdorf, Niklas, Xin Ding, Julia K. Tietze, & Thomas Hanke. (2007). Characterization of mouse CD4 T cell subsets defined by expression of KLRG1. European Journal of Immunology. 37(12). 3445–3454. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sadanori Furudate Breakdown of academic impact, for papers by Azusa Miyashita Breakdown of academic impact, for papers by Joanna Mangana Breakdown of academic impact, for papers by Courtney W. Hudgens Breakdown of academic impact, for papers by Laura K. Fogli Breakdown of academic impact, for papers by Mitali Manzur Breakdown of academic impact, for papers by Leila Jeskanen Breakdown of academic impact, for papers by Amy J. Petty Breakdown of academic impact, for papers by Jochen T. Schaefer Breakdown of academic impact, for papers by Özge Uluçkan
Rankless by CCL
2026